# Bellevue Group AG 13F holdings Q2 2026: $4.8 billion

Bellevue Group AG reported $4.8 billion in 13F securities across 148 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Amgen Inc at $308 million, 6.5% of the reported value. Since Q1 2026 it opened 17 new positions and exited 24.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $4,752,644,375
- Positions: 148
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1674546
- Form 13F file number: 028-17462
- Business address: Theaterstrasse 12, Zurich, CH-8001 Switzerland
- SEC filing: [0001104659-26-096739](https://www.sec.gov/Archives/edgar/data/1674546/000110465926096739/0001104659-26-096739-index.htm)

## Top 25 holdings by value

The largest of 148 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Amgen Inc](https://specstream.ai/data/institutional-holders/amgen-inc-031162100) | COM | 851,550 | $308.4 million | +556,192 |
| [Vertex Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/vertex-pharmaceuticals-inc-92532f100) | COM | 578,634 | $287.4 million | -103,274 |
| [Argenx Se](https://specstream.ai/data/institutional-holders/argenx-se-04016x101) | SPONSORED ADR | 301,000 | $279.3 million | -12,000 |
| [Gilead Sciences Inc](https://specstream.ai/data/institutional-holders/gilead-sciences-inc-375558103) | COM | 2,158,772 | $272.7 million | +988,893 |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 1,048,014 | $196.3 million | -496,442 |
| [Oruka Therapeutics Inc](https://specstream.ai/data/institutional-holders/oruka-therapeutics-inc-687604108) | COM | 1,657,190 | $157.7 million | +1,150,182 |
| [Insmed Inc](https://specstream.ai/data/institutional-holders/insmed-inc-457669307) | COM PAR $.01 | 1,393,418 | $148.6 million | +1,383,384 |
| [Scholar Rock HLDG Corp](https://specstream.ai/data/institutional-holders/scholar-rock-hldg-corp-80706p103) | COM | 2,449,547 | $134.7 million | -1,135,026 |
| [Nuvalent Inc](https://specstream.ai/data/institutional-holders/nuvalent-inc-670703107) | COM | 1,053,268 | $130.1 million | No change |
| [Viridian Therapeutics Inc](https://specstream.ai/data/institutional-holders/viridian-therapeutics-inc-92790c104) | COM | 6,731,909 | $123.7 million | +5,765 |
| [Relay Therapeutics Inc](https://specstream.ai/data/institutional-holders/relay-therapeutics-inc-75943r102) | COM | 6,185,970 | $115.7 million | -1,609,272 |
| [Vaxcyte Inc](https://specstream.ai/data/institutional-holders/vaxcyte-inc-92243g108) | COM | 1,971,935 | $114.6 million | +781,238 |
| [United Therapeutics Corp Del](https://specstream.ai/data/institutional-holders/united-therapeutics-corp-del-91307c102) | COM | 188,515 | $102.1 million | +186,438 |
| [Intuitive Surgical Inc](https://specstream.ai/data/institutional-holders/intuitive-surgical-inc-46120e602) | COM NEW | 254,809 | $101.3 million | -31,845 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/institutional-holders/regeneron-pharmaceuticals-75886f107) | COM | 157,291 | $98.1 million | -121,383 |
| [Crinetics Pharmaceuticals in](https://specstream.ai/data/institutional-holders/crinetics-pharmaceuticals-in-22663k107) | COM | 2,620,000 | $98 million | -660,000 |
| [Bridgebio Pharma Inc](https://specstream.ai/data/institutional-holders/bridgebio-pharma-inc-10806x102) | COM | 1,189,506 | $88.6 million | +1,164,129 |
| [Immunocore Hldgs PLC](https://specstream.ai/data/institutional-holders/immunocore-hldgs-plc-45258d105) | ADS | 2,788,245 | $88.5 million | -8,558 |
| [Abbott Laboratories](https://specstream.ai/data/institutional-holders/abbott-laboratories-002824100) | COM | 947,115 | $85.9 million | -204,520 |
| [Stryker Corporation](https://specstream.ai/data/institutional-holders/stryker-corporation-863667101) | COM | 268,461 | $84.5 million | +51,224 |
| [Medtronic PLC](https://specstream.ai/data/institutional-holders/medtronic-plc-g5960l103) | SHS | 994,233 | $77.8 million | +36,904 |
| [Ionis Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/ionis-pharmaceuticals-inc-462222100) | COM | 972,258 | $77.1 million | -846,407 |
| [Enliven Therapeutics Inc](https://specstream.ai/data/institutional-holders/enliven-therapeutics-inc-29337e102) | COM | 1,490,000 | $75.6 million | -830,867 |
| [Vera Therapeutics Inc](https://specstream.ai/data/institutional-holders/vera-therapeutics-inc-92337r101) | CL A | 1,710,808 | $73.4 million | +37 |
| [Jade Biosciences Inc](https://specstream.ai/data/institutional-holders/jade-biosciences-inc-008064206) | COM NEW | 3,057,996 | $67.9 million | -443,506 |

## New positions in Q2 2026

17 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Avalyn Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/avalyn-pharmaceuticals-inc-05348y105) | COM SHS | 1,350,000 | $44.4 million |
| [CG Oncology Inc](https://specstream.ai/data/institutional-holders/cg-oncology-inc-156944100) | COM | 493,596 | $35.1 million |
| [Seaport Therapeutics Inc](https://specstream.ai/data/institutional-holders/seaport-therapeutics-inc-81221k108) | COMMON STOCK | 1,100,000 | $23.9 million |
| [Palvella Therapeutics Inc Ne](https://specstream.ai/data/institutional-holders/palvella-therapeutics-inc-ne-697947109) | COM | 155,000 | $23.7 million |
| [Spyre Therapeutics Inc](https://specstream.ai/data/institutional-holders/spyre-therapeutics-inc-00773j202) | COM NEW | 229,931 | $20.4 million |
| [Hemab Therapeutics Hldgs Inc](https://specstream.ai/data/institutional-holders/hemab-therapeutics-hldgs-inc-423494103) | COM SHS | 550,000 | $20.2 million |
| [Parabilis Medicines Inc](https://specstream.ai/data/institutional-holders/parabilis-medicines-inc-698955101) | COM | 500,000 | $13.7 million |
| [Aura Biosciences Inc](https://specstream.ai/data/institutional-holders/aura-biosciences-inc-05153u107) | COM | 1,166,667 | $8.3 million |
| [Molina Healthcare Inc](https://specstream.ai/data/institutional-holders/molina-healthcare-inc-60855r100) | COM | 27,761 | $6.3 million |
| [GMR Solutions Inc](https://specstream.ai/data/institutional-holders/gmr-solutions-inc-38013d106) | COM CL A | 333,333 | $5.2 million |
| [Alamar Biosciences Inc](https://specstream.ai/data/institutional-holders/alamar-biosciences-inc-010911105) | COMMON STOCK | 55,738 | $1.5 million |
| [Mobia Med Inc](https://specstream.ai/data/institutional-holders/mobia-med-inc-60705v103) | COMMON STOCK | 100,000 | $1.3 million |
| [Veradermics Inc](https://specstream.ai/data/institutional-holders/veradermics-inc-922967104) | COMMON STOCK | 3,468 | $426,356 |
| [Definium Therapeutics Inc](https://specstream.ai/data/institutional-holders/definium-therapeutics-inc-24477v105) | COM SHS | 8,391 | $394,713 |
| [Viatris Inc](https://specstream.ai/data/institutional-holders/viatris-inc-92556v106) | COM | 15,778 | $250,555 |
| [Cogent Biosciences Inc](https://specstream.ai/data/institutional-holders/cogent-biosciences-inc-19240q201) | COM | 4,870 | $188,469 |
| [Waters Corp](https://specstream.ai/data/institutional-holders/waters-corp-941848103) | COM | 179 | $67,132 |

## Positions exited in Q2 2026

24 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Edgewise Therapeutics Inc](https://specstream.ai/data/institutional-holders/edgewise-therapeutics-inc-28036f105) | COM | 1,528,518 | $48.1 million |
| [Inspire Med Sys Inc](https://specstream.ai/data/institutional-holders/inspire-med-sys-inc-457730109) | COM | 99,735 | $5.1 million |
| [Penumbra Inc](https://specstream.ai/data/institutional-holders/penumbra-inc-70975l107) | COM | 12,267 | $4 million |
| [Atrium Therapeutics Inc](https://specstream.ai/data/institutional-holders/atrium-therapeutics-inc-04965n104) | COM | 263,096 | $3.5 million |
| Masimo Corp | COM | 8,753 | $1.6 million |
| [Equinor Asa](https://specstream.ai/data/institutional-holders/equinor-asa-29446m102) | SPONSORED ADR | 17,573 | $741,581 |
| [Exxon Mobil Corp](https://specstream.ai/data/institutional-holders/exxon-mobil-corp-30231g102) | COM | 4,370 | $741,414 |
| [BP PLC](https://specstream.ai/data/institutional-holders/bp-plc-055622104) | SPONSORED ADR | 15,644 | $735,268 |
| [Shell PLC](https://specstream.ai/data/institutional-holders/shell-plc-780259305) | SPON ADS | 7,844 | $729,492 |
| [Cisco Sys Inc](https://specstream.ai/data/institutional-holders/cisco-sys-inc-17275r102) | COM | 8,000 | $620,720 |
| [Alibaba Group HLDG LTD](https://specstream.ai/data/institutional-holders/alibaba-group-hldg-ltd-01609w102) | SPONSORED ADS | 4,700 | $589,662 |
| [Procter & Gamble Co](https://specstream.ai/data/institutional-holders/procter-gamble-co-742718109) | COM | 3,900 | $563,316 |
| [Mastercard Incorporated](https://specstream.ai/data/institutional-holders/mastercard-incorporated-57636q104) | CL A | 1,100 | $549,626 |
| [Blackrock Inc](https://specstream.ai/data/institutional-holders/blackrock-inc-09290d101) | COM | 450 | $432,770 |
| [Visa Inc](https://specstream.ai/data/institutional-holders/visa-inc-92826c839) | COM CL A | 1,400 | $423,136 |
| Centessa Pharmaceuticals PLC | SPONSORED ADS | 9,030 | $358,672 |
| [Jd.Com Inc](https://specstream.ai/data/institutional-holders/jd-com-inc-47215p106) | SPON ADS CL A | 11,000 | $325,270 |
| [Accenture PLC Ireland](https://specstream.ai/data/institutional-holders/accenture-plc-ireland-g1151c101) | SHS CLASS A | 1,500 | $297,435 |
| [Adobe Inc](https://specstream.ai/data/institutional-holders/adobe-inc-00724f101) | COM | 1,200 | $291,696 |
| [Olema Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/olema-pharmaceuticals-inc-68062p106) | COM | 16,443 | $245,165 |
| Ascendis Pharma A/S | SPONSORED ADR | 536 | $122,599 |
| [Bridgebio Oncology Therapeut](https://specstream.ai/data/institutional-holders/bridgebio-oncology-therapeut-107924102) | COM NEW | 6,982 | $62,489 |
| [Wave Life Sciences LTD](https://specstream.ai/data/institutional-holders/wave-life-sciences-ltd-y95308105) | SHS | 5,261 | $38,142 |
| [Qiagen NV](https://specstream.ai/data/institutional-holders/qiagen-nv-n72482156) | ORD SHARES | 243 | $9,730 |

## Also on SpecStream

- [Bellevue Group AG Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1674546/000110465926096739/0001104659-26-096739-index.htm)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Dialysis clinics in the United States](https://specstream.ai/data/businesses/dialysis-clinics/united-states)
- [Machine shops in the United States](https://specstream.ai/data/businesses/machine-shops/united-states)
- [Suppliers and distributors in the United States](https://specstream.ai/data/businesses/suppliers-and-distributors/united-states)
- [Business office supplies and stationery companies in the United States](https://specstream.ai/data/businesses/business-office-supplies-and-stationery-companies/united-states)
- [Honduran restaurants in the United States](https://specstream.ai/data/businesses/honduran-restaurants/united-states)
- [Public health clinics in the United States](https://specstream.ai/data/businesses/public-health-clinics/united-states)
